In ex vivo experiments, INT-747 significantly downregulates TNF-α, IL-17, and IFN-γ production in activated human peripheral blood mononuclear cells, purified CD14+ monocytes, and dendritic cells, and in the lamina propria mononuclear cells of patients with IBD. Here, IL17A is linked to irritable bowel syndrome.